SCHEMBL6929074

SCHEMBL6929074

CC(C)(C)OC(=O)N1CC[C@H](Oc2ccccc2CC(=O)OCc2ccccc2)C1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.46
JAK2 O60674 1/20 0.46
JAK1 P23458 1/20 0.46
USP30 Q70CQ3 1/20 0.46
HRH1 P35367 1/20 0.45
PDE4B Q07343 3/20 0.44
HTT P42858 1/20 0.44
STS P08842 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
PRMT5 O14744 1/20 0.42
WDR77 Q9BQA1 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM1A O60341 1/20 0.42
PIK3CD O00329 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6924027 0.89 L3MBTL1 (0.47) GPR119USP30PDE4BPRMT5WDR77
SCHEMBL6925099 0.89 USP30 (0.48) GPR119JAK2JAK1USP30PDE4B
SCHEMBL6926570 0.87 PDE4B (0.47) GPR119JAK2JAK1USP30PDE4B
SCHEMBL6929071 0.85 USP30 (0.53) GPR119JAK2JAK1USP30HTT
SCHEMBL6925955 0.84 GPR119 (0.48) GPR119JAK2JAK1USP30PDE4B
SCHEMBL18295360 0.82 GPR119 (0.50) GPR119JAK2JAK1USP30PDE4B
SCHEMBL16814814 0.81 USP30 (0.49) GPR119JAK2JAK1USP30HRH1
SCHEMBL16792796 0.81 USP30 (0.49) GPR119JAK2JAK1USP30HRH1
SCHEMBL15375880 0.79 USP30 (0.55) GPR119JAK2JAK1USP30STS
SCHEMBL15377844 0.79 USP30 (0.55) GPR119JAK2JAK1USP30STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515142-B2 Intermediates of aromatic amidine derivatives which have anticoagulation action DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-02-04 US disclosed
US-20020062033-A1 Process for preparing 2-phenyl-3-naphthylpropionic acid derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-05-23 US disclosed
US-6337405-B1 MULTISTAGE REACTION OF PYRROLE SUBSTITUTED WITH SULFONATE GROUPS AND HYDROXYPHENYLACETIC ACID DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-01-08 US disclosed
US-6252088-B1 COUPLING A NITRILE CONTAININ NAPHTHALENE COMPOUND WITH A COMPOUND CONTAINING PROPIONIC ACID GROUP DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-06-26 US disclosed
EP-0936215-A1 PROCESS FOR PREPARING 2-PHENYL-3-NAPHTHYLPROPIONIC ACID DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1999-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020062033-A1 Process for preparing 2-phenyl-3-naphthylpropionic acid derivatives PROC, F12, F2 GPR119 4825/4885JAK2 3515/4885JAK1 2269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.